Summit Therapeutics
SMMT
#2244
Rank
C$11.41 B
Marketcap
C$14.27
Share price
-5.87%
Change (1 day)
-37.50%
Change (1 year)

Earnings for Summit Therapeutics (SMMT)

Earnings in 2026 (TTM): -C$1.17 Billion

According to Summit Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$1.55 Billion a decrease over its 2024 earnings that were of -C$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Summit Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$1.17 Billion-24.65%
2025 -C$1.55 Billion387.84%
2024 -C$0.32 Billion-64.01%
2023 -C$0.89 Billion680.54%
2022 -C$0.12 Billion-11.08%
2021 -C$0.13 Billion67.46%
2020 -C$75.88 Million29.71%
2019 -C$58.5 Million
2014 -C$45.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-C$0.19 Billion-84.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.24 Million-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-C$0.22 Billion-81.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-C$0.9 Billion-24.71%๐Ÿ‡บ๐Ÿ‡ธ USA